// App-Quantinova.ai

435 : SOX9 predicts progression of liver fibrosis in patients with chronic hepatitis C

Researchers

Presenter

  • Varinder S. Athwal

Principal Investigators

  • James Pritchett

  • Abed Zaitoun

  • William Irving

  • Indra Neil Guha

  • Neil Hanley

  • Karen Piper Hanley

Medical Centers

  • Division of Diabetes, Endocrinology and Gastroenterology, University of Manchester, Manchester, United Kingdom

  • Department of Histopathology, University Hospital of South Manchester (U.K.), Manchester, United Kingdom

  • School of Healthcare Science, Manchester Metropolitan University, Manchester, United Kingdom

  • Department of Haematology, Nottingham City Hospital, Nottingham, United Kingdom

  • Oncology Department - City Campus, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom

  • NIHR BRU in Gastroenterology and Hepatology, University of Nottingham, Nottingham, United Kingdom

  • Department of Gastroenterology and Hepatology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom

  • Research and Innovation Department, Central Manchester NHS Foundation Trust, Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Hepatitis C

  • Hepatic fibrosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved